Concepedia

Anand Shah

AS

5

Publications

302

Citations

5

H-Index

2018

Active since

Affiliations

University of California, San Francisco(Current)

United States Food and Drug Administration

Massachusetts General Hospital

Harvard University

Anand Shah is an author at University of California, San Francisco specializing in epidemiology, covid-19, and medicine.

ORCID

Top concepts

Publications per year

2018–2024

5

Publications

5

FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Anand Shah, Erik Bloomquist, Shenghui Tang et al. · Clinical Cancer Research · 2018 · 106 citations

Unwavering Regulatory Safeguards for COVID-19 Vaccines

Anand Shah, Peter Marks, Stephen M. Hahn · JAMA · 2020 · 58 citations

, , +12

Advancing digital health: FDA innovation during COVID-19

Kushal T. Kadakia, Bakul Patel, Anand Shah · npj Digital Medicine · 2020 · 50 citations · Full text

2024 Update of the RECOVER-Adult Long COVID Research Index

Linda N. Geng, Kristine M. Erlandson, Mady Hornig et al. · JAMA · 2024 · 48 citations · Full text

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study

Zoe Swank, Ella Borberg, Yulu Chen et al. · Clinical Microbiology and Infection · 2024 · 40 citations · Full text

, , +6

Rows per page

1–5 of 5